Gain Therapeutics, Inc.
GANX
$1.65
-$0.04-2.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.63% | -26.91% | -60.47% | -28.36% | -38.16% |
| Total Receivables | 4.82% | 111.02% | 351.53% | 255.92% | 215.66% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 32.36% | -30.10% | -7.06% | 25.38% | -39.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 91.66% | -23.46% | -49.80% | -19.56% | -34.74% |
|
|
|||||
| Total Current Assets | 91.66% | -23.46% | -49.80% | -19.56% | -34.74% |
| Net Property, Plant & Equipment | 26.51% | -32.70% | -26.77% | -43.32% | -44.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -23.45% | -26.68% | -19.10% | -25.35% | -30.56% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.72% | 4.33% | 41.70% | 31.98% | 22.93% |
| Total Assets | 88.22% | -23.63% | -48.77% | -20.26% | -34.85% |
|
|
|||||
| Total Accounts Payable | -12.82% | 43.58% | 32.55% | 53.10% | -28.26% |
| Total Accrued Expenses | -6.59% | -7.12% | -36.41% | 3.72% | 14.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.59% | -18.71% | -11.92% | -16.99% | -22.21% |
| Total Finance Division Other Current Liabilities | -84.08% | -92.10% | -93.69% | -76.17% | -76.88% |
| Total Other Current Liabilities | -84.08% | -92.10% | -93.69% | -76.17% | -76.88% |
| Total Current Liabilities | -14.29% | -9.23% | -20.33% | 0.49% | -20.98% |
|
|
|||||
| Total Current Liabilities | -14.29% | -9.23% | -20.33% | 0.49% | -20.98% |
| Long-Term Debt | -8.59% | -20.55% | -13.32% | -20.74% | -26.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 294.03% | -32.43% | -30.83% | -82.75% | -76.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -20.48% | 35.65% | 37.99% | 31.98% | 22.10% |
| Total Liabilities | -11.08% | -7.22% | -17.18% | -1.53% | -20.67% |
|
|
|||||
| Common Stock & APIC | 34.20% | 18.67% | 11.73% | 24.80% | 21.43% |
| Retained Earnings | -24.83% | -25.05% | -25.49% | -32.30% | -33.58% |
| Treasury Stock & Other | 413.90% | 131.96% | 4,572.80% | -647.49% | -200.12% |
| Total Common Equity | 152.94% | -33.67% | -68.64% | -33.12% | -41.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 152.94% | -33.67% | -68.64% | -33.12% | -41.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 152.94% | -33.67% | -68.64% | -33.12% | -41.65% |
|
|
|||||